Maria Carolina Gelli

ORCID: 0000-0002-3335-8389
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Uterine Myomas and Treatments
  • Soft tissue tumor case studies
  • Celiac Disease Research and Management
  • Sarcoma Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • IgG4-Related and Inflammatory Diseases
  • Gynecological conditions and treatments
  • Microscopic Colitis
  • Cancer and Skin Lesions
  • Cancer Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Gastrointestinal Tumor Research and Treatment
  • Digestive system and related health
  • Radiopharmaceutical Chemistry and Applications
  • Bladder and Urothelial Cancer Treatments
  • Medical Imaging and Pathology Studies
  • Gastrointestinal disorders and treatments
  • Metastasis and carcinoma case studies
  • Urinary and Genital Oncology Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Risks and Factors
  • Eosinophilic Esophagitis
  • HER2/EGFR in Cancer Research
  • Amoebic Infections and Treatments

Azienda Sanitaria Unità Locale di Reggio Emilia
1996-2023

Istituti di Ricovero e Cura a Carattere Scientifico
2013-2023

Institut Gustave Roussy
2019

Ospedale Santa Maria
2002-2015

Azienda Ospedaliera S.Maria
1993-2013

University of Modena and Reggio Emilia
2012

Santa Maria Nuova Hospital
2002

University of Bologna
1968-1992

Policlinico S.Orsola-Malpighi
1987

HNF1B (formerly known as TCF2) gene encodes for a transcription factor that regulates expression involved in normal mesodermal and endodermal developments. A close association between rs4430796 polymorphism of decreased endometrial cancer (EC) risk has been demonstrated. The aim the current study was to test hypothesis can influence prognosis EC patients. Retrospective cohort study. Clinical pathological data were extrapolated genotypes assessed on formalin-fixed paraffin-embedded non-tumour...

10.1186/s12885-015-1246-5 article EN cc-by BMC Cancer 2015-04-06

Objectives: The ABO blood group antigens were found on most epithelial cells and in secretions. In the normal endometrium there is a variable expression of histo-blood related suggesting hormonal regulation. A relationship between groups endometrial cancer has been investigated with contradictory results. this study we influence types clinical pathological characteristics patients. Method: Retrospective cohort study. Clinical data extrapolated their association assessed. Results: total 203...

10.7150/jca.19524 article EN cc-by-nc Journal of Cancer 2017-01-01

Hematometra is an unusual occurrence in young women undergoing conization; moreover, osseous metaplasia of the uterine cervix a very rare event, with 7 cases literature. A postconization hematometra due to endocervical ossification unique occurrence. The authors report such event.A woman conization developed progressive hypoamenorrhea pelvic pain. Pregnancy test was negative and transvaginal ultrasound showed image suspected hematometra. Diagnostic hysteroscopy obstruction bone formation...

10.1097/lgt.0b013e3182914eef article EN Journal of Lower Genital Tract Disease 2013-08-17

The distribution of lysozyme in normal and pathological human gastric colonic mucosa was studied by light electron microscopic immunocytochemical techniques compared with histological histochemical features. Lysozyme localized pyloric glandular epithelial cells, mucous neck cells fundic glands, Paneth some crypt the mature mucosa. In addition, detected a large spectrum “immature” or “regenerative” epithelium: regenerative zone, undifferentiated columnar surface hyperplastic interfoveolar...

10.1111/j.1699-0463.1992.tb03969.x article EN Apmis 1992-07-01

Background: A progressive delay in the age of first conception results an increased frequency endometrial cancer patients reproductive and desiring childbearing. Case: 38-year-old infertile woman with stage I endometrioid adenocarcinoma was treated gonadotropin releasing hormone agonist (GnRHa) levonorgestrel-releasing intrauterine device (LNG-IUD). After disease remission, she underwent a controlled ovarian stimulation for standard vitro fertilization (IVF) program had pregnancy delivering...

10.3109/09513590.2012.738726 article EN Gynecological Endocrinology 2012-11-16

The enzyme cyclooxygenase 2 is an inducible expressed at sites of inflammation and in a variety malignant solid tumors such as endometrial cancer (EC). In EC patients, its over-expression correlated with progressive disease poor prognosis. expression encoded by polymorphic gene, called PTGS2. aim the current study was to test hypothesis that rs5275 polymorphism PTGS2 influence prognosis patients. This paper retrospective cohort study. Clinical pathological data were extrapolated genotypes...

10.1007/s13277-015-3424-0 article EN Tumor Biology 2015-04-21

10.1016/j.ajog.2012.01.028 article EN American Journal of Obstetrics and Gynecology 2012-01-31

Uterine leiomyomas usually arise from the uterine body (95%), and rarely cervix (0.6%) or other urogenital sites. Lipoleiomyomas are benign, uncommon variants of (0.03-0.2%), histologically composed smooth muscle cells mature adipocytes; they occur in exceptionally cervix. We performed first systematic literature review cervical lipoleiomyomas (PRISMA guidelines), presenting five new cases. Including our series, thirty-one detailed cases were reported (mainly Asia). The age range was 35-74...

10.3390/jpm12111852 article EN Journal of Personalized Medicine 2022-11-06

The distribution of intermediate-filament (IF) proteins the keratin, vimentin and desmin type in breast stromal sarcomas, carcinosarcomas, metaplastic carcinomas phyllodes tumors has been compared using avidin-biotin complex immunoperoxidase technique. Keratin reactivity was found carcinomatous pseudosarcomatous areas all carcinomas, cuboidal epithelial cells carcinosarcomas component tumors. Vimentin were detected sarcomatous portion carcinosarcoma, focally not always sarcomas. These data...

10.1177/172460088700200205 article EN The International Journal of Biological Markers 1987-05-01
Coming Soon ...